Clinical Guidelines

Mary B. Daly, MD, PhD, FACP, received National Comprehensive Cancer Network’s Rodger Winn Award.

Studies that feature work participation as an outcome in patients with inflammatory arthritis should identify key contextual factors — such as job type or social security system — upfront, according to new “points to consider” from EULAR.

The American College of Gastroenterology published clinical guidelines regarding the management of patients with overt upper gastrointestinal bleeding.

Despite an ever-growing array of therapeutic options, patients with antineutrophil cytoplasmic antibody-associated vasculitis often fail to achieve remission, according to a speaker at the ACR State-of-the-Art Clinical Symposium.

Shared decision-making and clinical judgment are key to effectively managing osteoarthritis patients, especially when sets of osteoarthritis guidelines disagree on the best course of action, noted a speaker at the ACR State-of-the-Art Clinical Symposium.

In this episode, Brian E. Lacy, MD, PhD, joins us to discuss the American College of Gastroenterology’s newest guidelines for irritable bowel syndrome, options for patients with IBS-D and IBS-C, and much more.

Given the global deluge of data investigating COVID-19 in patients with rheumatic and immune-mediated diseases, clinicians continue to struggle with divergent evidence and recommendations, noted a speaker at the ACR State-of-the-Art Clinical Symposium.

Amid positive results from large clinical trials confirming the benefits of transcatheter aortic valve replacement, along with expanded indications from the FDA, recently updated recommendations represent the already widespread acceptance of less invasive interventions for aortic stenosis.

While many of the forthcoming American College of Rheumatology guidelines for rheumatoid arthritis capture the reality of clinical practice, some recommendations are “puzzling,” according to a speaker at the ACR State-of-the-Art Clinical Symposium.

An updated guideline for best practices in managing anaplastic thyroid cancer stresses the need for patient-centered care, considering disease stage and quality of life before attempting aggressive disease management.